Why community pharmacies are ideal for CVD screening

Community pharmacies are ideally placed to offer population-based screening for cardiovascular disease (CVD), report Australian researchers.

But governments will need to provide funding and policy support to make it happen, say Dr Kevin McNamara and colleagues in their paper, which has been accepted for publication in the journal Heart Lung and Circulation.

Dr McNamara says the study offers the “most detailed exploration to date in community pharmacy of screening and monitoring as it relates to absolute CVD risk”.

The research was based on a survey of 294 Australian community pharmacies asking them about their experience in offering screening services.

It found while 96% of respondents offered blood pressure readings, a minority screened for other common risk factors.

This was despite 79% having private counselling areas and 59% indicating capacity to screen for multiple